Position in INSM
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$570,203
-$302,666 QoQ
Shares Held
5,348
+0.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#388
of 663 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fulton Bank, N.A. holds $5,566,847 across 7 Biotechnology names. INSM ranks #4 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
17,286 | $1,959,540 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,081 | $1,297,586 | |
| 3 | TECH |
BIO-TECHNE Corp
|
8,152 | $575,938 | |
| 4 | INSM |
INSMED Inc
This page
|
5,348 | $570,203 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
987 | $490,272 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,505 | $453,050 | |
| 7 | QURE |
uniQure N.V.
|
4,782 | $220,258 |
All Filings in INSM
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $570,203 | 5,348 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $872,869 | 5,338 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $926,762 | 5,325 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $745,827 | 5,179 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $545,066 | 5,416 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $341,473 | 4,476 | Shares | Sole | 2025-04-09 | |
| No filing history on record for this holder in this stock. | ||||||